Skip to main content Accessibility help
×
Home

Clinical implications of mechanisms of action of antidepressants

  • Brian Leonard

Extract

The purpose of this review is briefly to consider the biological basis of depression and to attempt to illustrate how antidepressants produce their beneficial effects by correcting these abnormalities.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Clinical implications of mechanisms of action of antidepressants
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Clinical implications of mechanisms of action of antidepressants
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Clinical implications of mechanisms of action of antidepressants
      Available formats
      ×

Copyright

References

Hide All
Agren, H. (1980) Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolities in the cerebrospinal fluid: II. Suicide. Psychiatric Research, 3, 225236.
Blier, P., de Montigny, C. & Chaput, Y. (1990) A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. Journal of Clinical Psychiatry, 51, 1420.
Charney, D. S., Delgado, P. L., Price, L. H. et al (1991) The receptor sensitivity hypothesis of antidepressant action. In The Role of Serotonin in Psychiatric Disorders (eds Brown, S.-L. & van Praag, H. M.) pp. 2756. New York: Brunner/Mazel.
Delgado, P.L., Charney, D. S., Price, L. H. et al (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry, 47, 411418.
Dinan, T. G. (1994). Glucocorticoids and the genesis of depressive illness. A psychobiological model. British Journal of Psychiatry, 164, 365371.
Drevets, W. C. (1998) Functional neuroimaging studies of depression: the anatomy of melancholia. Annual Review of Medicine, 49, 341361.
Duman, R. S., Henninger, G. R. & Nestler, E. J. (1997) A molecular and cellular theory of depression. Archives of General Psychiatry, 54, 597606.
Earley, B., Glennon, M., Lally, M. et al (1994) Autoradiographic distribution of cholinergic nuscarinic receptors and serotonin2 receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine. Human Psychopharmacology, 9, 397407.
Janowsky, D. S., Risch, S. C., Kennedy, B. et al (1986) Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release. Psychopharmacology, 89, 150154.
Kitayama, I., Yaga, T., Kayahara, T. J. et al (1997) Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biological Psychiatry, 42, 687696.
Leonard, B. E. (1986) Neurotransmitter receptors, endocrine response and the biological substrates of depression: a review. Human Psychopharmacology, 1, 318.
Leonard, B. E. (1994a) Biological strategies for the development of antidepressants. CNS Drugs, 1, 285304.
Leonard, B. E. (1994b) Effect of antidepressants on specific neurotransmitters: are such effects relevant to their therapeutic action? In Handbook of Depression and Anxiety – A Biological Approach (eds den Boer, J. A. & Sitzen, J. M. A.) pp. 379404. New York: Marcel Dekker.
Lesser, I. M., Mena, I. & Boone, K.B. (1994) Reduction of cerebral blood flow in older depressed patients. Archives in General Psychiatry, 51, 677686.
Mansbach, R. S., Brooks, E. N. & Chen, Y. L. (1997) Antidepressant-like effects of CP-154, 526, a selective CRF receptor antagonist. European Journal of Pharmacology, 323, 2126.
McAskill, R., Mir, S. & Taylor, D. (1998) Pindolol augmentation of antidepressant therapy. British Journal of Psychiatry, 173, 203208.
Nugent, D. F. & Leonard, B. E. (1998) Platelet abnormalities in depression. Journal of Serotonin Research, 4, 251266.
O'Keane, V., O'Flynn, K., Lucey, J. et al (1992) Pyridostigmine induced growth hormone responses in healthy and depressed subjects – evidence for cholinergic supersensitivity in depression. Psychological Medicine, 22, 5560.
Racagni, G., Tinelli, D. & Bianchi, E. (1991) cAMP dependent binding proteins and endogneous phosphorylation after antidepressant treatment. In Hydroxytryptamine in Psychiatry (eds Sandler, M., Coppen, A. & Hartnet, S.) (5th edn), pp. 116123. Oxford: Oxford Medical Publications.
Reynolds, I. J. & Miller, R. J. (1988) Tricyclic antidepressants block N-methyl-D-aspartate receptor: similarities to the action of zinc. British Journal of Pharmacology, 95, 95102.
Siuciak, J. A., Lewis, D., Wiegand, S. J. et al (1996) Antidepressant like effect of brain derived neutrophic factor. Pharmacology, Biochemistry and Behavior, 56, 131137.
Song, C. & Leonard, B. E. (1995) The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants on immune function. Human Psychopharmacology, 10, 718.
Tome, M. B., Isaac, M.T., Harte, R. et al (1997) Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. International Clinical Psychopharmacology, 12, 8189.
World Health Organization Mental Health Collaborating Centres (1989) Pharmacotherapy of depressive disorders: a consensus statement. Journal of Affective Disorders, 17, 197198.
Wong, K. L., Bruch, R. C. & Farbman, A. I. (1991) Amitriptyline-mediated inhibition of neurite outgrowth from chick embryonic cerebral explants involves a reduction in adenylate cyclase activity. Journal of Neurochemistry, 57, 12231230.
Willner, P. (1983) A conceptual framework for psychobiological synthesis. Biological Psychiatry, 18, 14471450.

Related content

Powered by UNSILO

Clinical implications of mechanisms of action of antidepressants

  • Brian Leonard

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Clinical implications of mechanisms of action of antidepressants

  • Brian Leonard
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *